Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.37 |
| ▸ | TACR1 | P25103 | 3/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | FLT1 | P17948 | 1/20 | 0.33 |
| ▸ | FLT4 | P35916 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26478686 | 0.89 | OPRM1 (0.40) | ALDH1A1MAPTNPSR1OPRM1TACR1 | |
| SCHEMBL24944298 | 0.88 | NPC1 (0.45) | MAPTOPRM1TACR1NPC1PKM | |
| SCHEMBL26478764 | 0.87 | OPRM1 (0.41) | ALDH1A1MAPTNPSR1OPRM1TACR1 | |
| SCHEMBL26478661 | 0.86 | OPRM1 (0.38) | ALDH1A1MAPTNPSR1OPRM1TACR1 | |
| SCHEMBL24944297 | 0.86 | OPRM1 (0.38) | MAPTOPRM1TACR1NPC1PKM | |
| SCHEMBL26478683 | 0.86 | PTPN2 (0.41) | ALDH1A1MAPTNPSR1OPRM1TACR1 | |
| SCHEMBL26478639 | 0.85 | GSTA1 (0.43) | ALDH1A1MAPTNPSR1OPRM1 | |
| SCHEMBL24944623 | 0.84 | RXFP1 (0.46) | ALDH1A1NPSR1OPRM1NPC1PKM | |
| SCHEMBL26478643 | 0.84 | OPRM1 (0.39) | MAPTOPRM1TACR1NPC1RAB9A | |
| SCHEMBL26478751 | 0.84 | OPRM1 (0.41) | ALDH1A1MAPTNPSR1OPRM1TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11644753-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-09 | — | — | US | disclosed |
| US-11644753-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11644753-B2 | Resist composition and patterning process | HNRNPU, NSUN2, HNRNPR | ALDH1A1 4767/4885MAPT 2648/4885NPSR1 2668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.